Skip to main content
Sri Obulareddy, MD, Oncology, Little Rock, AR

SriJObulareddyMD

Oncology Little Rock, AR

Breast Cancer, Hematologic Oncology, Thoracic Cancer

Hematologist/Oncologist

Dr. Obulareddy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Obulareddy's full profile

Already have an account?

Education & Training

  • University of Texas Medical Branch Hospitals
    University of Texas Medical Branch HospitalsFellowship, Medical Oncology, 2014 - 2016
  • University of Texas Medical Branch Hospitals
    University of Texas Medical Branch HospitalsResidency, Internal Medicine, 2011 - 2014
  • Stephen F. Austin State University
    Stephen F. Austin State UniversityMS, Occupational Medicine, Environmental Health, 2006 - 2009
  • Stephen F. Austin State University
    Stephen F. Austin State UniversityM.S., Occupational and Environmental Health, 2006 - 2009
  • Andhra Medical College NTR
    Andhra Medical College NTRClass of 2004

Certifications & Licensure

  • AR State Medical License
    AR State Medical License 2022 - 2025
  • WA State Medical License
    WA State Medical License 2017 - 2024
  • ND State Medical License
    ND State Medical License 2016 - 2023
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Best overall clinical research award The University of Texas Medical Branch, 2012

Publications & Presentations

PubMed

Journal Articles

  • Trends of MRI use to Evaluate Breast Cancer in the Texas Medicare Population  
    Techksell M Washington1, Solly Silwan Chedid1*, Wei Zhang1, Celia Chao1, Sri Obulareddy1, Yong-Fang Kuo1,2, Catherine Cooksley1,2 and Gulshan Sharma, Journal of Cancer Prevention and Current Research, 10/31/2016
  • Phase 1 study of Pazopanib and Ixabepilone in Patients with Solid Tumors: To determine the optimal tolerated regimen (OTR) of combination Pazopanib and Ixabepilone dur...  
    Ganesan C, Obulareddy SJ, Fischer J, Pharm D, Antonysamy M, Jha G, Bliss R, Dudek A, American Journal of Clinical Oncology, 1/1/2016
  • Phase I Study of Pazopanib and Ixabepilone in Patients With Solid Tumors  
    Ganesan C, Obulareddy SJ, Fischer JH, Antonysamy MA, Jha G, Bliss RL, Dudek AZ., American Journal of Clinical Oncology, 2/2014
  • Join now to see all

Lectures

  • Phase 1 study of Pazopanib and Ixabepilone in Patients with Solid Tumors: To determine the optimal tolerated regimen (OTR) of combination Pazopanib and Ixabepilone dur... 
    Washington, DC, 2013; University of Texas Medical Branch, Galveston, TX, 2013 - 1/1/2013
  • Annual Foot Exam in patients with type -2 Diabetes Mellitus 
    University of Texas Medical Branch, Galveston, TX - 1/1/2013

Press Mentions

  • Board-Certified Oncologist Sri Obulareddy, M.D., Joins UAMS Winthrop P. Rockefeller Cancer Institute
    Board-Certified Oncologist Sri Obulareddy, M.D., Joins UAMS Winthrop P. Rockefeller Cancer InstituteFebruary 22nd, 2023

Professional Memberships

Other Languages

  • Hindi, Telugu